SEC Tracker
Get the app

Entero Therapeutics GRDX

Renaissance Technologies LLC filed a Schedule 13G disclosing a 5.1% passive stake in Entero Therapeutics, Inc. (ENTO), a biopharmaceutical company. This regulatory filing indicates Renaissance has crossed the 5% ownership threshold in ENTO, signaling a potentially influential investment position that investors should monitor.

Ownership stake disclosure by RENAISSANCE TECHNOLOGIES LLC

Form
Schedule 13G
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Entero Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 4931 and related industry codes: the same peer list as the financial tables.

  1. OPAL Fuels OPAL public float $65M, Jun 30, 2025
  2. Aedis Energy ADIS public float $2M, Jun 30, 2025
  3. Genie Energy GNE public float $512M, Jun 30, 2025
  4. Unitil UTL public float $833M, Jun 30, 2025
  5. Ocean Thermal Energy CPWR public float $181K, Jun 30, 2025